These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31638654)

  • 1. Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
    Björklund E; Nielsen SJ; Hansson EC; Karlsson M; Wallinder A; Martinsson A; Tygesen H; Romlin BS; Malm CJ; Pivodic A; Jeppsson A
    Eur Heart J; 2020 May; 41(17):1653-1661. PubMed ID: 31638654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic Factors, Secondary Prevention Medication, and Long-Term Survival After Coronary Artery Bypass Grafting: A Population-Based Cohort Study From the SWEDEHEART Registry.
    Nielsen SJ; Karlsson M; Björklund E; Martinsson A; Hansson EC; Malm CJ; Pivodic A; Jeppsson A
    J Am Heart Assoc; 2020 Mar; 9(5):e015491. PubMed ID: 32114890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for secondary prevention and major adverse events after coronary artery bypass grafting.
    Pan E; Nielsen SJ; Mennander A; Björklund E; Martinsson A; Lindgren M; Hansson EC; Pivodic A; Jeppsson A
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1875-1886.e4. PubMed ID: 34893327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system inhibition and outcome after coronary artery bypass grafting: A population-based study from the SWEDEHEART registry.
    Martinsson A; Nielsen SJ; Björklund E; Pivodic A; Malm CJ; Hansson EC; Jeppsson A
    Int J Cardiol; 2021 May; 331():40-45. PubMed ID: 33359277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.
    Taha A; Nielsen SJ; Bergfeldt L; Ahlsson A; Friberg L; Björck S; Franzén S; Jeppsson A
    J Am Heart Assoc; 2021 Jan; 10(1):e017966. PubMed ID: 33251914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of cancer and survival after coronary artery bypass grafting: Experiences from the SWEDEHEART registry.
    Mennander AA; Nielsen SJ; Huhtala H; Dellgren G; Hansson EC; Jeppsson A
    J Thorac Cardiovasc Surg; 2022 Jul; 164(1):107-114.e1. PubMed ID: 33069428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registry.
    Baranowska J; Törngren C; Nielsen SJ; Lindgren M; Björklund E; Ravn-Fischer A; Skoglund K; Jeppsson A; Martinsson A
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):837-846. PubMed ID: 35583235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study.
    Lindgren M; Nielsen SJ; Björklund E; Pivodic A; Perrotta S; Hansson EC; Jeppsson A; Martinsson A
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):529-536. PubMed ID: 35102367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study on adherence to secondary prevention medications after coronary bypass surgery.
    Heitmann LA; Gudmundsdottir IJ; Jonsdottir F; Gudbjartsson T; Sigurdsson MI
    Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35134874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Factors, Sex, and Mortality Risk After Coronary Artery Bypass Grafting: A Population-Based Cohort Study.
    Nielsen S; Giang KW; Wallinder A; Rosengren A; Pivodic A; Jeppsson A; Karlsson M
    J Am Heart Assoc; 2019 Mar; 8(6):e011490. PubMed ID: 30852925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
    Persson J; Yan J; Angerås O; Venetsanos D; Jeppsson A; Sjögren I; Linder R; Erlinge D; Ivert T; Omerovic E
    Eur Heart J; 2023 Aug; 44(30):2833-2842. PubMed ID: 37288564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.
    Okrainec K; Pilote L; Platt R; Eisenberg MJ
    Can J Cardiol; 2006 Aug; 22(10):841-7. PubMed ID: 16957801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
    Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
    Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
    Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Cerebral Atherosclerosis According to Location on Prognosis after Coronary Artery Bypass Grafting.
    Lee EJ; Chung CH; Choi KH; Lee JW; Choo SJ; Jung SH; Kang DW; Kim JS; Kwon SU
    Cerebrovasc Dis; 2018; 46(5-6):200-209. PubMed ID: 30408800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postdischarge major bleeding, myocardial infarction, and mortality risk after coronary artery bypass grafting.
    Björklund E; Enström P; Nielsen SJ; Tygesen H; Martinsson A; Hansson EC; Lindgren M; Malm CJ; Pivodic A; Jeppsson A
    Heart; 2024 Mar; 110(8):569-577. PubMed ID: 38148160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-pump and off-pump coronary artery bypass grafting for patients needing at least two grafts: comparative outcomes at 20 years.
    Raja SG; Garg S; Soni MK; Rochon M; Marczin N; Bhudia SK; De Robertis F; Bahrami T
    Eur J Cardiothorac Surg; 2020 Mar; 57(3):512-519. PubMed ID: 31549144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.